Change language

Sidebar content	Main content
Actions Displays	Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer). Technology Appraisal Guidance - no. 23. 2001 Remove from selection Add to selection TitleGuidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer). Technology Appraisal Guidance - no. 23. 2001 Author NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE PublisherNATIONAL INSTITUTE FOR CLINICAL EXCELLENCE Year of publication2001 Pagination20PP MaterialBook MaterialBook SubjectBRAIN, NEUROLOGY, NEUROSURGERY, CARCINOMA

Main content

Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer). Technology Appraisal Guidance - no. 23. 2001

Add to selection

TitleGuidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer). Technology Appraisal Guidance - no. 23. 2001

Author

Year of publication2001

Pagination20PP

MaterialBook

AIS uses strictly necessary cookies to improve the user experience.

This AIS also uses analytical cookies.